表紙
市場調査レポート

子宮内膜症:主要9カ国の市場予測

Endometriosis Forecast in 9 Major Markets 2015-2025

発行 Black Swan Analysis 商品コード 339881
出版日 ページ情報 英文 36 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
子宮内膜症:主要9カ国の市場予測 Endometriosis Forecast in 9 Major Markets 2015-2025
出版日: 2015年09月01日 ページ情報: 英文 36 Pages
概要

子宮内膜症は、通常は子宮 (子宮内膜) の内側で生育する細胞が子宮の外側で発見される婦人科疾患です。これは重い月経、下腹部痛を引き起こし、また不妊問題の原因となり得る慢性疾患です。

当レポートでは、世界の主要9ヶ国 (米国、フランス、ドイツ、イタリア、スペイン、英国、ブラジル、日本、インド) における子宮内膜症の発症状況について分析し、疾患の概要や現時点での有病者数、性別・年代別 (5歳区切り) の詳細状況、地域別・民族別傾向、リスク要因、疾患の診断と予後、主な症状や合併症、将来的な動向見通し (今後10年間分) といった情報を取りまとめてお届けいたします。

図表

イントロダクション

疾患の原因

リスク要因と予防法

疾患の診断

地域別/民族別の差異

疾患の予後と臨床経過

疾患に関連する主な合併症/特徴

患者数の定量化の手法

子宮内膜症の最大有病者数

子宮内膜症の主な位置

子宮内膜症の主な併存疾患・後遺症

参考文献

付録

目次
Product Code: ENDO0010915

Summary

Endometriosis is a gynaecological condition where tissue that normally behaves like the lining of the womb (endometrium) is found outside the womb. These pieces of tissue are commonly found on the ovaries and the lining of the pelvis behind the uterus. This is a chronic condition that causes heavy periods, lower abdominal pain and can cause fertility issues. This report provides the current prevalent population for Endometriosis across 9 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Endometriosis. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Endometriosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Endometriosis include:

  • Infertility
  • Pelvic Pain
  • Fibroids
  • Ovarian cysts

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Endometriosis's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Endometriosis and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Endometriosis's prevalent population.
  • Examination of the prevalence of the different causative gene mutations for Endometriosis.
  • Identify sub-populations within Endometriosis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Endometriosis patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors and Prevention
  • Diagnosis of the Disease
  • Variation by Geography /Ethnicity
  • Disease Prognosis and Clinical Course
  • Key Co-Morbid Conditions / Features Associated with the Disease
  • Methodology for Quantifications of Patient Number
  • Top Line Prevalence for Endometriosis
  • Main Site of Endometriosis
  • Key Concomitant Conditions and Sequaelae of Endometriosis
  • References
  • Appendix

List of Tables and Figures

  • Prevalence of Endometriosis, females only (000s)
  • Prevalence of Endometriosis by Stage, females only (000s)
  • Endometriosis by Main Site, females only (000s)
  • Prevalence of Infertility in Patients with Endometriosis, females only (000s)
  • Prevalence of Ovarian Cysts in Patients with Endometriosis, females only (000s)
  • Endometriosis Patients with Chronic Pelvic Pain, females only (000s)
  • Prevalence of Fibroids in Patients with Endometriosis, females only (000s)
  • Endometriosis Patients with Incapacitating Dysmenorrhoea, females only (000s)
  • Endometriosis Patients with Cyclical Intestinal Complaints, females only (000s)
  • Endometriosis Patients wit Cyclical Urinary Complaints, females only (000s)
  • Endometriosis Patients with Deep Dyspareuria, females only (000s)
  • USA Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • France Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • United Kingdom Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of Endometriosis by 5-yr age cohort, females (000s)
  • India Prevalence of Endometriosis by 5-yr age cohort, females (000s)
Back to Top